T-DM1 Combined With CDK4/6 Inhibitor Ribociclib
Clinical trial NCT06481956 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06481956
- Sponsor
- Zheng Yabing
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2027-01-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.